Average Co-Inventor Count = 2.61
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. E. R. Squibb Sons, Inc. (30 from 1,624 patents)
2. Bristol-myers Squibb Compnay (5 from 3,681 patents)
3. Other (1 from 832,680 patents)
4. Squibb & Sons, Inc. (0 patent)
5. Slusarchyk, William A. (0 patent)
6. Dejneka, Tamara (0 patent)
7. Gordon, Eric M. (0 patent)
8. Koster, William H. (0 patent)
37 patents:
1. 6846838 - Ureido-substituted aniline compounds useful as serine protease inhibitors
2. 6642252 - Acid derivatives useful as serine protease inhibitors
3. 6472414 - Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
4. 6344450 - Lactam compounds and their use as inhibitors of serine proteases and method
5. 6335324 - Beta lactam compounds and their use as inhibitors of tryptase
6. 5760246 - Conformationally restricted aromatic inhibitors of microsomal
7. 5723609 - Bis (hydroxymethyl) cyclobutyl purines
8. 5369098 - Hydroxymethyl cyclobutyl purines
9. 5340816 - Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
10. 5206244 - Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
11. 5185459 - Bis protected (hydroxymethyl)cyclobutanols
12. H001142 - Optically active cyclobutyl pyrimidine
13. 5130462 - Cyclobutane derivatives
14. 5126345 - Bis (hydroxymethyl) cyclobutyl triazolopyrimidines
15. 4812564 - Process for preparing 4,4-dialkyl-2-azetidinones utilizing a pyridine